Eli Lilly is developing a groundbreaking one-time gene-editing treatment that could permanently lower bad cholesterol and reduce heart disease risk. Bloomberg's Madison Muller joins Open Interest to break down the science, the risks, and why Lilly is racing to expand beyond obesity drugs into its next major growth era.
Ferrari's first fully electric car is already dividing fans. Critics say the $640K EV looks more like a Nissan Leaf or "a bar of soap" than a Ferrari, but the company may not care. Bloomberg's Craig Trudell joins Open Interest to explain why Ferrari only needs a handful of wealthy buyers to make the Luce a success, and how the brand could use the EV to unlock access to future supercars.
Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion as it looks to become a leader in infectious diseases. The drugmaker has been using cash from its obesity drugs to expand into other disease areas. Bloomberg's Gerry Smith reports.
On this episode of Stock Movers: - AutoZone (AZO) shares fall after the retailer of automotive replacement parts posted comparable sales for the third quarter that fell short of Wall Street's expectations. - Ferrari (RACE IM) shares fell almost 8% after critics panned the look of its first fully electric vehicle, a setback for the Italian super-car maker's controversial push into EVs. - Eli Lilly (LLY) agreed to buy three vaccine developers for as much as $3.8 billion, marking the drugmaker's re-entry into the infectious disease space.
Space and satellite stocks are surging as SpaceX begins its IPO roadshow. Elon Musk's company filed last week for what stands to be the biggest initial public offering ever. On Friday, the company's Starship launched and successfully deployed mock satellites before returning to Earth safely. Bloomberg's Ed Ludlow reports.
Strategy has retired $1.5 billion in convertible debt at a discount while increasing its Bitcoin holdings to 843,738 BTC.
UBS raised its price target on Micron to a Street-high view of $1,625, up from $535. Mandeep Singh has more on "Bloomberg Open Interest."
Gregory Daco, EY-Parthenon chief economist, says he thinks former Federal Reserve Chair Jerome Powell will not be afraid to dissent as a member of the board of governors. Daco speaks on "Bloomberg Surveillance."
Bill Dudley, former New York Fed President and Bloomberg Opinion columnist, examines the effectiveness of Federal Reserve policy and the central bank's credibility on inflation. His opinions are his own.
US and Iranian forces clashed near the Strait of Hormuz overnight, hours after US President Donald Trump reiterated that negotiations with Tehran to extend their ceasefire and reopen the strait were proceeding, and just before a published statement from Iran's Supreme Leader Mojtaba Khamenei. Tyler Kendall reports on Bloomberg Television.
Eli Lilly (NYSE:LLY) announced an aggressive expansion into the infectious disease prevention sector, entering into definitive agreements to acquire three distinct vaccine developers for a combined potential value of up to $3.83 billion in cash.
Sonal Desai, executive VP at Franklin Templeton Fixed Income, views the Federal Reserve as "very, very dovish" and says the market is not pricing in realistically what long-end yields would be.
_1406990_640x360_2501377603587-640x360.webp&w=3840&q=75)
